Battery Life can Save a Life – support Diabetes Australia 5 June 2018 For the third consecutive year, in support of National Diabetes Week, Energizer® will donate $1 for every specially marked pack purchased to Diabetes Australia. By buying a specially marked battery pack, buyers will be supporting the life-changing work of Diabetes Australia. The funds raised will help Diabetes Australia to support people living with diabetes and fund life-saving diabetes research through the Diabetes Australia Research Program. The program funds the nation’s best diabetes researchers in their bid to discover better treatments for people with diabetes, and to ultimately find a cure. Energizer® has 120 years history of innovation in batteries and is currently the maker of the world’s longest lasting AA battery (Energizer® Ultimate Lithium ™). Diabetes Australia CEO Professor Greg Johnson said it was pleasing that Energizer® has chosen to support National Diabetes Week for a third year by raising funds and awareness for the cause. “We are delighted that Energizer is once again choosing to support Diabetes Australia in its efforts to raise awareness of diabetes and the need for more diabetes research,” said Professor Greg Johnson. “A cure for diabetes remains our hope – and our national research program brings us closer and closer to a breakthrough.” “It is important that we work with peak consumer bodies, such as Diabetes Australia, to support people in our community. We are proud to stand alongside Diabetes Australia on their journey for a better future for people living with diabetes.” said David Pattinson, Business Director, Energizer®. Support life-saving research by buying a longer lasting battery and improve the lives of people living with diabetes. Your purchase will go towards Diabetes Australia – helping Australia’s diabetes community. Keep an eye out for the Energizer® $1 donation stickers in stores near you. Written by: Diabetes Australia
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading